Food allergy immunotherapy can improve quality of life by reducing reaction risk, but treatment demands, reactions, and daily routines require balanced expectations, monitoring, and patient-centered decision-making.

A five-minute screening tool helps identify high-risk endometriosis earlier, enabling faster evaluation, symptom management, and referral to improve quality of life and reduce diagnostic delays.

Oral contraceptives commonly cause manageable side effects affecting comfort, adherence, and safety; clear counseling, risk screening, and personalized adjustments help maintain effective, consistent contraception and overall health outcomes.

Habit formation is central to sustainable behavior change in healthcare, helping patients turn small, repeatable actions into routines that improve adherence, outcomes, and long-term management of chronic conditions.

Hidden AI tools embedded in clinical systems subtly influence decisions, workflows, and access to care, raising concerns about transparency, bias, patient safety, and accountability in healthcare delivery.

Lifestyle habits—including diet, exercise, sleep, and substance use—significantly influence fertility by affecting hormones, ovulation, and sperm health, making preconception lifestyle care essential for improving conception outcomes.

GPRC5D-targeted immunotherapies offer new hope for relapsed multiple myeloma, but tumors increasingly evade treatment through multimodal antigenic escape, challenging long-term control and therapy sequencing decisions.

Emerging research links interferon gamma signaling to drug resistance in acute myeloid leukemia, suggesting immune pathways influence relapse risk, therapy response, and future precision treatment strategies.

Insurance type influences access to high-quality poststroke care; dual-eligible and Medicare Advantage patients are less likely than traditional Medicare beneficiaries to receive top-rated skilled nursing or home health services.

Oral contraceptives may cause yeast infections, dryness, libido changes, spotting, breast tenderness, mood shifts, or rare blood clots, requiring counseling, monitoring, and personalized adjustments to maintain safety and adherence.